Prasugrel
Prasugrel
Prasugrel (pronounced prah-SOO-grel) is a medication used to prevent blood clots in people with acute coronary syndrome or undergoing percutaneous coronary intervention (PCI).
Etymology
The name "Prasugrel" is derived from the chemical name of the drug, which is 5-[(1RS)-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate.
Usage
Prasugrel works by inhibiting platelet activation and aggregation, which are key steps in the formation of blood clots. It is a member of the thienopyridine class of antiplatelet agents, which also includes clopidogrel and ticlopidine.
Side Effects
Common side effects of Prasugrel include bleeding, headache, dizziness, fatigue, nausea, and shortness of breath. Severe side effects may include major bleeding, allergic reactions, and thrombotic thrombocytopenic purpura (TTP).
Related Terms
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Thienopyridine
- Clopidogrel
- Ticlopidine
- Thrombotic Thrombocytopenic Purpura
See Also
External links
- Medical encyclopedia article on Prasugrel
- Wikipedia's article - Prasugrel
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski